Loading page…
Cosmo Pharmaceuticals NV 2025 Sustainability Report
Company: Cosmo Pharmaceuticals NV
Sector: Manufacturing
Country: Ireland
Year: 2025
Type: Sustainability Report
Pages: 85
The report describes Cosmo's 2025 ESG progress, including a 20.3% year-on-year reduction in direct Scope 1 and 2 emissions. The company screened 919 suppliers, representing over 99% of supplier spend, through its EcoVadis risk-screening program. Women held 40% of management roles, exceeding the company's stated 2028 target ahead of schedule.
Indicators available in this report: